Patrick has developed deep methodological expertise advising pharma and biotech firms during his more than 10 years in serving clients. His core competencies span across R&D and Commercial, developing solutions from early research asset strategies over late-stage prioritization to medical affairs reorganizations. He is a well-known expert around portfolio management, asset valuations and market entry strategies across a diverse set of therapeutic areas. Patrick has supported a variety of different organization types in the US, Europe and Asia to identify growth opportunities and increase shareholder value.
Prior to ClearView, Patrick held positions at A.T. Kearney, where he was part of the European Health & Lifesciences leadership team, built the European Center of Excellence for Biotechnology, and leveraged Data Science and Artificial Intelligence for faster and more robust decision making in R&D.
He holds an MBA of the University of St. Gallen, Switzerland and conducts research on strategic decision making at the IE University, Spain.
Debbi Amanti Belanger
Vini De Nadalal